T1	Participants 336 367	80 boys aged two to eight years
T2	Participants 498 552	caudal 0.25% plain bupivacaine 0.5 mL.kg(-1) (Group I)
T3	Participants 556 625	0.25% plain bupivacaine 0.5 mL.kg(-1) with neostigmine (Groups II-IV)
T4	Participants 923 947	Group I (5.1 +/- 2.3 hr)
T5	Participants 986 1004	other three groups
T6	Participants 1312 1333	Groups II, III and IV
T7	Participants 1151 1158	Group I
T8	Participants 1484 1514	comparable in all four groups.
